Healthcare
Hospitals
from 1,920 today
Narayana Hrudayalaya reported 39% YoY EBITDA growth at INR4.7bn, impacted by headwinds in the UK and Cayman businesses, while the India business registered a strong quarter with 40% YoY EBITDA growth. We maintain our 'BUY' rating with a target price of INR2,350/share.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
